Is there a kink in consumers' threshold value for cost-effectiveness in health care?

被引:105
|
作者
O'Brien, BJ
Gertsen, K
Willan, AR
Faulkner, LA
机构
[1] St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada
[2] Univ Nijmegen, Nijmegen, Netherlands
[3] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
关键词
willingness to pay; willingness to accept; cost-effectiveness;
D O I
10.1002/hec.655
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: A reproducible observation is that Consumers' willingness-to-accept (WTA) monetary compensation to forgo a program is greater than their stated willingness-to-pay (WTP) for the same benefit. Several explanations exist, including the psychological principle that the utility of losses weighs heavier than gains. We sought to quantify the WTP-WTA disparity from published literature and explore implications for cost-effectiveness analysis accept-reject thresholds in the south-west quadrant of the cost-effectiveness plane (less effect, less cost)Methods: We reviewed published studies (health and non-health) to estimate the ratio of WTA to WTP for the same program benefit for each study and to determine if WTA is consistently greater than WTP in the literature. Results: WTA,WTP ratios were greater than unity for every study we reviewed. The ratios ranged from 3.2 to 89.4 for environmental studies (n = 7), 1.9 to 6.4 for health care studies (n = 2) 1.1 to 3.6 for safety studies (n = 4) and 13 to 2.6 for experimental studies (n = 7). Conclusions: Given that WTA is greater than WTP based on individual preferences, should not societal preferences used to determine cost-effectiveness thresholds reflect this disparity! Current convention in cost-effectiveness analysis is that any given accept-rejection criterion (e.g. $50 k/QALY gained) is symmetric - a straight line through the origin of the cost-effectiveness plane. The WTA-WTP evidence suggests a downward 'kink' through the origin for the south-west quadrant, such that the 'selling price' of a QALY is greater than the 'buying price'. The possibility of 'kinky cost-effectiveness' decision rules and the size of the kink merits further exploration. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
下载
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [21] HEALTH-CARE ECONOMICS - COST-EFFECTIVENESS OF RHEUMATOLOGY
    VANDERLINDEN, S
    BAKKER, C
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 248 - 248
  • [22] Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope
    Luyten, Jeroen
    Denier, Yvonne
    SOCIAL JUSTICE RESEARCH, 2019, 32 (02) : 155 - 171
  • [23] Needs and cost-effectiveness in health care priority setting
    Gustavsson, Erik
    Tinghog, Gustav
    HEALTH AND TECHNOLOGY, 2020, 10 (03) : 611 - 619
  • [24] Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope
    Jeroen Luyten
    Yvonne Denier
    Social Justice Research, 2019, 32 : 155 - 171
  • [25] Uncertainty analyses of cost-effectiveness measures in health care
    Aven, T.
    Eidesen, K.
    SAFETY AND RELIABILITY FOR MANAGING RISK, VOLS 1-3, 2006, : 1755 - +
  • [26] Needs and cost-effectiveness in health care priority setting
    Erik Gustavsson
    Gustav Tinghög
    Health and Technology, 2020, 10 : 611 - 619
  • [27] Cost-effectiveness of quality improvement programs in health care
    Gandjour, A
    Lauterbach, KW
    MEDIZINISCHE KLINIK, 2002, 97 (08) : 499 - 502
  • [28] The cost-effectiveness of methadone maintenance as a health care intervention
    Barnett, PG
    ADDICTION, 1999, 94 (04) : 479 - 488
  • [29] COST-EFFECTIVENESS IN HEALTH-CARE - COMPLEXITY OF THE EQUATION
    ARCHAMBAULT, A
    JOURNAL OF THE CANADIAN DIETETIC ASSOCIATION-REVUE DE L ASSOCIATION CANADIENNE DES DIETETISTES, 1988, 49 (02): : 80 - 85
  • [30] A QALY ALTERNATIVE FOR COST-EFFECTIVENESS ANALYSIS IN HEALTH CARE
    Gandjour, A.
    VALUE IN HEALTH, 2009, 12 (03) : A22 - A22